{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:55:33Z","timestamp":1760784933991},"reference-count":105,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T00:00:00Z","timestamp":1611705600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Muscle and Nerve"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The clinical course of neuromuscular disorders (NMDs) can be affected by infections, both in immunocompetent individuals, and in those with reduced immunocompetence due to immunosuppressive\/immunomodulating therapies. Infections and immunizations may also trigger NMDs. There is a potential for reduced efficacy of immunizations in patients with reduced immunocompetence. The recent vaccination program for coronavirus disease\u20102019 (COVID\u201019) raises several questions regarding the safety and efficacy of this vaccine in individuals with NMDs. In this Practice Topic article, we address the role of vaccine\u2010preventable infections in NMDs and the safety and efficacy of immunization in individuals with NMDs, with emphasis on vaccination against COVID\u201019.<\/jats:p>","DOI":"10.1002\/mus.27179","type":"journal-article","created":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T15:20:44Z","timestamp":1611156044000},"page":"294-303","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Doctor\u2014Should I get the <scp>COVID<\/scp>\u201019 vaccine? Infection and immunization in individuals with neuromuscular disorders"],"prefix":"10.1002","volume":"63","author":[{"given":"Sasha A.","family":"\u017divkovi\u0107","sequence":"first","affiliation":[{"name":"Department of Neurology University of Pittsburgh Medical Center  Pittsburgh Pennsylvania USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Gruener","sequence":"additional","affiliation":[{"name":"Department of Neurology, Stritch School of Medicine Loyola University  Chicago Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pushpa","family":"Narayanaswami","sequence":"additional","affiliation":[{"name":"Department of Neurology Harvard Medical School\/Beth Israel Deaconess Medical Center  Boston Massachusetts USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the AANEM Quality and Patient Safety Committee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2021,1,27]]},"reference":[{"key":"e_1_2_13_2_1","unstructured":"US Food and Drug Administration. EUA for first Covid19 vaccine. December 11 2020.https:\/\/www.fda.gov\/emergency-preparedness-and-response\/coronavirus-disease-2019-covid-19\/pfizer-biontech-covid-19-vac. Accessed December 30 2020."},{"key":"e_1_2_13_3_1","unstructured":"US Food and Drug Administration. Moderna COVID\u201019 vaccine EUA letter of approval. December 18 2020.https:\/\/www.fda.gov\/media\/144636\/download. Accessed December 30 2020."},{"key":"e_1_2_13_4_1","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.05250"},{"key":"e_1_2_13_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/35066006"},{"key":"e_1_2_13_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f5061"},{"key":"e_1_2_13_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofu024"},{"key":"e_1_2_13_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14153"},{"key":"e_1_2_13_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-018-8751-9"},{"key":"e_1_2_13_10_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000008688"},{"key":"e_1_2_13_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.17.2188"},{"key":"e_1_2_13_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.72.853.641"},{"key":"e_1_2_13_13_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2012.00037"},{"key":"e_1_2_13_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-019-03435-3"},{"key":"e_1_2_13_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.21465"},{"key":"e_1_2_13_16_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1529-8027.2001.006001021.x"},{"key":"e_1_2_13_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/00019052-200010000-00014"},{"key":"e_1_2_13_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-63849-6.00016-5"},{"key":"e_1_2_13_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2013.05.006"},{"key":"e_1_2_13_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410350717"},{"key":"e_1_2_13_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13365-020-00872-x"},{"key":"e_1_2_13_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.24141"},{"key":"e_1_2_13_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20113"},{"key":"e_1_2_13_24_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00001-08"},{"key":"e_1_2_13_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00339-1"},{"key":"e_1_2_13_26_1","doi-asserted-by":"publisher","DOI":"10.1086\/594124"},{"key":"e_1_2_13_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27024"},{"key":"e_1_2_13_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25987"},{"key":"e_1_2_13_29_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000044399.71601.EA"},{"key":"e_1_2_13_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2019.01.007"},{"key":"e_1_2_13_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.26382"},{"key":"e_1_2_13_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.26032"},{"key":"e_1_2_13_33_1","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2020000116"},{"key":"e_1_2_13_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2340"},{"key":"e_1_2_13_35_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190701411441"},{"key":"e_1_2_13_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-020-00427-y"},{"key":"e_1_2_13_37_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000011124"},{"key":"e_1_2_13_38_1","doi-asserted-by":"publisher","DOI":"10.1177\/1060028016650107"},{"issue":"10","key":"e_1_2_13_39_1","first-page":"CD005590","article-title":"Prophylaxis for pneumocystis pneumonia (PCP) in non\u2010HIV immunocompromised patients","volume":"2014","author":"Stern A","year":"2014","journal-title":"Cochrane Database Syst Rev."},{"key":"e_1_2_13_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-05-781450"},{"key":"e_1_2_13_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit684"},{"key":"e_1_2_13_42_1","unstructured":"Advisory Committee on Immunization Practices. Altered immunocompetence. general best practice guidelines for immunization: best practices guidance of the Advisory Committee on Immunization Practices (ACIP).https:\/\/www.cdc.gov\/vaccines\/hcp\/acip-recs\/general-recs\/immunocompetence.html. Accessed December 30 2020."},{"key":"e_1_2_13_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22246"},{"key":"e_1_2_13_44_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-04-494096"},{"key":"e_1_2_13_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.09.003"},{"key":"e_1_2_13_46_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200932040-00005"},{"key":"e_1_2_13_47_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a112795"},{"key":"e_1_2_13_48_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.20.2478"},{"key":"e_1_2_13_49_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199812173392501"},{"key":"e_1_2_13_50_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000009180"},{"key":"e_1_2_13_51_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu005"},{"key":"e_1_2_13_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(10)70140-7"},{"key":"e_1_2_13_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8027.2009.00243.x"},{"key":"e_1_2_13_54_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir960"},{"key":"e_1_2_13_55_1","unstructured":"US Centers for Disease Control and Prevention. Guillain\u2010Barr\u00e9 syndrome and vaccines 2020.https:\/\/www.cdc.gov\/vaccinesafety\/concerns\/guillain-barre-syndrome.html. Accessed December 30 2020."},{"key":"e_1_2_13_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14044"},{"key":"e_1_2_13_57_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.73.3.348"},{"key":"e_1_2_13_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.10.063"},{"key":"e_1_2_13_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2013.08.005"},{"key":"e_1_2_13_60_1","unstructured":"World Health Organization. Weekly epidemiological update\u2010December 29 2020.https:\/\/www.who.int\/publications\/m\/item\/weekly-epidemiological-update-29-december-2020. Accessed December 30 2020."},{"key":"e_1_2_13_61_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2008-3"},{"key":"e_1_2_13_62_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-020-0688-y"},{"key":"e_1_2_13_63_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01472-06"},{"key":"e_1_2_13_64_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00645-06"},{"key":"e_1_2_13_65_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi036155b"},{"key":"e_1_2_13_66_1","unstructured":"World Health Organization. SARS\u2010CoV2 new variants:https:\/\/www.who.int\/csr\/don\/31-december-2020-sars-cov2-variants\/en\/. Accessed January 7 2021."},{"key":"e_1_2_13_67_1","unstructured":"US Centers for Disease Control and Prevention. SARS\u2010CoV2 new variants.https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/more\/scientific-brief-emerging-variant.html. Accessed January 7 2021."},{"key":"e_1_2_13_68_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-020-09944-5"},{"key":"e_1_2_13_69_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.1127"},{"key":"e_1_2_13_70_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-324491"},{"key":"e_1_2_13_71_1","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000781"},{"key":"e_1_2_13_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105960"},{"key":"e_1_2_13_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.07.072"},{"key":"e_1_2_13_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2020.10.131"},{"key":"e_1_2_13_75_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27055"},{"key":"e_1_2_13_76_1","first-page":"1","article-title":"Mononeuritis multiplex: an unexpectedly frequent feature of severe COVID\u201019","author":"Needham E","year":"2020","journal-title":"J Neurol."},{"key":"e_1_2_13_77_1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14564"},{"key":"e_1_2_13_78_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27105"},{"key":"e_1_2_13_79_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27003"},{"key":"e_1_2_13_80_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000009566"},{"key":"e_1_2_13_81_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2031085"},{"key":"e_1_2_13_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2020.12.006"},{"key":"e_1_2_13_83_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2028436"},{"key":"e_1_2_13_84_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2027906"},{"key":"e_1_2_13_85_1","unstructured":"US Centers for Disease Control and Prevention\/Infectious Diseases Society of America. Vaccine candidates with published results from Phase 1\u20133 clinical trials [updated 12\/10\/2020].https:\/\/www.idsociety.org\/globalassets\/idsa\/public-health\/covid-19\/vaccines-table-12-10-20.pdf. Accessed December 30 2020."},{"key":"e_1_2_13_86_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034577"},{"key":"e_1_2_13_87_1","unstructured":"US Centers for Disease Control and Prevention. COVID\u201019 vaccines and severe allergic reactions 2020 [updated December 19 2020].https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/safety\/allergic-reaction.html. Accessed December 30 2020."},{"key":"e_1_2_13_88_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2035389"},{"key":"e_1_2_13_89_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6947e3"},{"key":"e_1_2_13_90_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6949e1"},{"key":"e_1_2_13_91_1","unstructured":"US Centers for Disease Control and Prevention. High risk influenza populations.https:\/\/www.cdc.gov\/flu\/highrisk\/index.htm. Accessed January 6 2021."},{"key":"e_1_2_13_92_1","unstructured":"US Centers for Disease Control and Prevention. Immunization and immunocompetence.https:\/\/www.cdc.gov\/vaccines\/hcp\/acip-recs\/general-recs\/immunocompetence.html. Accessed January 6 2021."},{"key":"e_1_2_13_93_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215882"},{"key":"e_1_2_13_94_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.144998"},{"key":"e_1_2_13_95_1","unstructured":"US Centers for Disease Control and Prevention. Latent tuberculosis infection. A guide for primary healthcare providers. 2020.https:\/\/www.cdc.gov\/tb\/publications\/ltbi\/pdf\/LTBIbooklet508.pdf. Accessed December 30 2020."},{"key":"e_1_2_13_96_1","first-page":"1","article-title":"Prevention and control of influenza with vaccines: recommendations of the advisory committee on immunization practices (ACIP), 2010","volume":"59","author":"Fiore AE","year":"2010","journal-title":"MMWR Recomm Rep."},{"key":"e_1_2_13_97_1","unstructured":"US Centers for Disease Control and Prevention. Pneumococcal vaccination: summary of who and when to vaccinate.https:\/\/www.cdc.gov\/vaccines\/vpd\/pneumo\/hcp\/who-when-to-vaccinate.html. Accessed December 30 2020."},{"key":"e_1_2_13_98_1","unstructured":"US Centers for Disease Control and Prevention. Frequently asked questions about Shingrix 2020.https:\/\/www.cdc.gov\/vaccines\/vpd\/shingles\/hcp\/shingrix\/faqs.html. Accessed December 30 2020."},{"key":"e_1_2_13_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2019.11.015"},{"key":"e_1_2_13_100_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6909a1"},{"key":"e_1_2_13_101_1","unstructured":"ThomasCF LimperAH. Treatment and prevention ofPneumocystis pneumoniain HIV\u2010uninfected patients. [updated 05\/09\/2019].https:\/\/www.uptodate.com\/contents\/treatment-and-prevention-of-pneumocystis-pneumonia-in-hiv-uninfected-patients?search=treatment-and-prevention-of-pneumocystis-pneumonia-in-non-hiv-infected-patients%26x003F;source%26x003D;search_result%26x0026;search%26x003D;pcp%26x002B;prophylaxis%26x0026;selectedTitle%26x003D;1%26x0025;7E51&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1. Accessed December 30 2020."},{"key":"e_1_2_13_102_1","unstructured":"US Centers for Disease Control and Prevention. Interim clinical considerations for use of mRNA COVID\u201019 vaccines currently authorized in the United States 2020 [updated 12\/30\/20].https:\/\/www.cdc.gov\/vaccines\/covid-19\/info-by-product\/clinical-considerations.html. Accessed December 30 2020."},{"key":"e_1_2_13_103_1","unstructured":"US Centers for Disease Control and Prevention. Covid vaccine safety.https:\/\/www.cdc.gov\/vaccines\/covid-19\/info-by-product\/clinical-considerations.html. Accessed January 6 2021."},{"key":"e_1_2_13_104_1","unstructured":"US Centers for Disease Control and Prevention. Ensuring the safety of COVID\u201019 vaccines in the United States 2020 [updated December 22 2020].https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/safety.html. Accessed December 30 2020."},{"key":"e_1_2_13_105_1","unstructured":"US Centers for Disease Control and Prevention. Live and inactivated vaccines.https:\/\/www.cdc.gov\/vaccines\/hcp\/acip-recs\/index.html. Accessed December 30 2020."},{"key":"e_1_2_13_106_1","unstructured":"US Centers for Disease Control and Prevention. Adult immunization schedule.https:\/\/www.cdc.gov\/vaccines\/schedules\/hcp\/imz\/adult.html. Accessed December 30 2020."}],"container-title":["Muscle &amp; Nerve"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mus.27179","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/mus.27179","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mus.27179","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T05:20:12Z","timestamp":1693545612000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/mus.27179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,27]]},"references-count":105,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["10.1002\/mus.27179"],"URL":"https:\/\/doi.org\/10.1002\/mus.27179","archive":["Portico"],"relation":{},"ISSN":["0148-639X","1097-4598"],"issn-type":[{"type":"print","value":"0148-639X"},{"type":"electronic","value":"1097-4598"}],"subject":[],"published":{"date-parts":[[2021,1,27]]},"assertion":[{"value":"2021-01-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-16","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}